The California Institute for Regenerative Medicine (CIRM) and the Chinese Ministry of Science and Technology (MOST) have agreed to collaborate on stem cell research. The agreement will make it easier to form cross-border teams that are working in similar areas. If the teams’ funding requests are approved, the researchers in each country will be supported by their respective agency, CIRM or MOST. The formal announcement, made today, adds details to a story that ChinaBio® Today originally broke late last week (…)
“Our collaboration will benefit patients in our countries and patients around the globe,” said Wan Gang, Minister, MOST. “We
Image by engineroomblog via Flickr
Using skin cells from people with type 1 diabetes, researchers were able to produce cells that made insulin in response to changing blood sugar levels, though not as efficiently as normal insulin-producing cells do. (…) “This is a big deal,” said Susan Solomon, CEO of the New York Stem Cell Foundation, which provided some of the funding for the study. “Tackling the basic biology of type 1 diabetes, which is a very complex disease, is a critical step. With these cells, we can see in a dish what’s happening to the immune system, and if
The latest developments in molecular biology in the prenatal diagnostic field, particularly regarding preserving stem cells extracted from amniotic liquid, were the focus of the latest S.I.Di.P conference (Italian Society of Prenatal Diagnosis and Maternal Fetal Medicine).
After a greeting from S.I.Di.P President Claudio Giorlandino and President of the Italian Gynecology and Obstetrics Society Giorgio Vittori, Professor Giuseppe Simone, the head of the Biocell Center in Busto Arsizio (VA), the first Italian center able to treat and store stem cells extracted from the amniotic liquid in liquid nitrogen, opened the conference.
“In the next five to ten years,” explained Professor Simoni,
The British mega-brand Virgin has launched a stem-cell bank in Qatar. The country has lofty goals of becoming the world leader in stem cell technologies, and unlike in the West, Qatar does not face some of the ethical issues surrounding stem-cell research.
It was a lavish launch for the opening of Qatar’s new research center that brought out billionaire Richard Branson and Qatar’s royal family to the country’s new Science and Technology Park.
Branson came to Qatar to open the Virgin Health Bank, the first in the region that collects stem cells from the umbilical cord blood of newborns.
“Qatar is a
In a landmark paper, researchers at Stanford University have described a new way to derive human induced pluripotent stem cells (iPSCs) without the use of contaminating mouse feeder cells. Using adipose cells as the starting cell population and mTeSR1, a defined medium that allows the expansion of human embryonic and induced pluripotent stem cells without the use of feeders, the researchers were able to fully reprogram the cells to the pluripotent state.
mTeSR1 is a fully defined medium and is the most widely used feeder-independent method for culturing human pluripotent stem cells, with citations in more than 25 publications.